{"name":"Centro Ortopedico y Quirurgico del Pie","slug":"centro-ortopedico-y-quirurgico-del-pie","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"propanolol","genericName":"propanolol","slug":"propanolol","indication":"Other","status":"marketed"},{"name":"Hand antisepsis with Propanolol- 1 60%.","genericName":"Hand antisepsis with Propanolol- 1 60%.","slug":"hand-antisepsis-with-propanolol-1-60","indication":"Hand antisepsis (non-standard/unconventional use)","status":"marketed"},{"name":"Triclosan 0.5 % Topical Solution","genericName":"Triclosan 0.5 % Topical Solution","slug":"triclosan-0-5-topical-solution","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"propanolol","genericName":"propanolol","slug":"propanolol","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Hand antisepsis with Propanolol- 1 60%.","genericName":"Hand antisepsis with Propanolol- 1 60%.","slug":"hand-antisepsis-with-propanolol-1-60","phase":"marketed","mechanism":"Propranolol is a non-selective beta-adrenergic receptor antagonist that reduces heart rate and blood pressure; however, its use as a hand antisepsis agent at 60% concentration is non-standard and likely reflects a topical antimicrobial application rather than its typical systemic cardiovascular mechanism.","indications":["Hand antisepsis (non-standard/unconventional use)"],"catalyst":""},{"name":"Triclosan 0.5 % Topical Solution","genericName":"Triclosan 0.5 % Topical Solution","slug":"triclosan-0-5-topical-solution","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"marketed":3},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}